Global Anti-obesity Drugs Market- Bausch Health Companies Inc., Currax Pharmaceuticals LLC, F. Hoffmann-La Roche Ltd., among others to contribute to the market growth

View Our Exclusive report on Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Download FREE Sample Report in Minutes!

The report on the anti-obesity drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. There is an increasing need for drugs that show sustained, long-term efficacy, which, in turn, is providing immense opportunities for vendors in the market to come up with innovative products. The market is driven by a limited number of approved drugs. 

The anti-obesity drugs market analysis includes type segment and geography landscape. This study identifies the research on drugs that target both obesity and type 2 diabetes mellitus as one of the prime reasons driving the anti-obesity drugs market growth during the next few years. The increasing epidemic of obesity and type 2 diabetes is encouraging several researchers and vendors in the market to research on drugs that can counter both obesity and type 2 diabetes. 

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. 

Get FREE Sample Report in Minutes!

The anti-obesity drugs market covers the following areas:
Anti-obesity Drugs Market Sizing
Anti-obesity Drugs Market Forecast
Anti-obesity Drugs Market Analysis

Get FREE Sample Report in Minutes!

Companies Mentioned

• Bausch Health Companies Inc.
• Currax Pharmaceuticals LLC
• F. Hoffmann-La Roche Ltd.
• Gelesis Inc.
• GlaxoSmithKline Plc
• Novo Nordisk AS
• RECORDATI S.p.A.
• Rhythm Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• VIVUS Inc.

Related Reports on Health Care Include:

• Endoscopic Closure Devices Market by Product and Geography - Forecast and Analysis 2021-2025- The endoscopic closure devices market size has the potential to grow by USD 579.00 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.88%. Get FREE sample report in minutes
   
• Marine Pharmaceuticals Market by Product, Source, and Geography - Forecast and Analysis 2021-2025- The marine pharmaceuticals market size has the potential to grow by USD 1.43 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 7.60%. Get FREE sample report in minutes

Key Topics Covered:

Executive Summary

Market Landscape

• Market ecosystem
• Market characteristics
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Five Forces Summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Class III anti-obesity drugs - Market size and forecast 2020-2025
• Class II anti-obesity drugs - Market size and forecast 2020-2025
• Class I anti-obesity drugs - Market size and forecast 2020-2025
• Market opportunity by Type

Market segmentation by Mechanism of Action

• Market segments
• Centrally acting anti-obesity drugs
• Peripherally acting anti-obesity drugs
• Other anti-obesity drugs

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Overview
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Bausch Health Companies Inc.
• Currax Pharmaceuticals LLC
• F. Hoffmann-La Roche Ltd.
• Gelesis Inc.
• GlaxoSmithKline Plc
• Novo Nordisk AS
• RECORDATI S.p.A.
• Teva Pharmaceutical Industries Ltd.
• VIVUS Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report Link: Get FREE Sample Report in Minutes!

SOURCE Technavio

Related Links

http://www.technavio.com/